Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Sector Catalysts

Jones Act

The law requiring goods shipped between U.S. ports to move on American-built, -crewed, -flagged vessels.

Also known as: Merchant Marine Act of 1920, Cabotage Law

What it is
The Jones Act requires that cargo transported between U.S. ports travel on vessels built, owned, flagged, and crewed by Americans. It protects the domestic maritime industry. Waivers are occasionally granted in emergencies.
What it does
The law guarantees demand for U.S. shipbuilders and domestic carriers, especially in coastal, offshore-wind, and Puerto Rico trades. Waiver debates and offshore-wind buildout are catalysts. Investors watch policy and vessel-supply dynamics.
The evidence
Offshore-wind projects have driven demand for Jones Act-compliant vessels, benefiting U.S. shipbuilders and specialized vessel operators.
Best for
U.S. shipbuilders and carriers: HII, MATX (Matson), KEX (Kirby).
Pairs well with
buy-american, appropriations, ndaa
Use cautiously with
Waivers and limited vessel supply complicate the thesis; assuming the Act guarantees smooth capacity ignores fleet shortages.
Cautions
Repeal proposals surface periodically, adding policy risk to the protected franchise.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo